As of April 18, 2025, Elevai Labs (ELAB) has a market cap of $1.838 million USD. According to our data, Elevai Labs is ranked No.9176 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $1.84 M |
-73.88%
|
Dec 31, 2024 | $7.04 M |
-99.37%
|
Dec 29, 2023 | $1.12 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Evolus
EOLS
|
$0.69 B |
-0.000 M
|
![]() USA
|
![]() Journey Medical
DERM
|
$0.14 B |
37.500 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
Market Cap | = | ELAB Stock Price | * | ELAB Shares Outstanding |
= | $2.60 | * | 0.71 M | |
= | $1.84 M |